Drug Topics

OCTOBER 10, 2024

Researchers analyzed the potential role of nonphysician health care providers to provide vaccine services outside of traditional health care settings.

Vaccines 497

Vaccines 497

STAT

OCTOBER 10, 2024

Nearly 60% of the experts who reviewed manuscripts for four prominent medical journals received at least one payment from industry during a recent three-year period and, overall, these reviewers or their institutions received more than $1 billion from companies, according to a new analysis. Between 2020 and 2022, 1,155 of the 1,962 experts who reviewed studies for The BMJ, JAMA, The Lancet, and The New England Journal of Medicine received some form of payment.

143

143

Drug Topics

OCTOBER 10, 2024

Additional research is needed to determine if the therapy can help with cognitive symptoms of post–COVID-19 condition.

236

236

STAT

OCTOBER 10, 2024

Telehealth providers treating opioid use disorder, ADHD, and women’s health issues say the sector is in a state of frustration and chaos as the pandemic-era flexibilities that allowed their businesses to thrive are set to end with no new rules in sight. With just months to go before the ability to prescribe controlled substances online dramatically changes overnight, the vacuum of information is forcing them to devote significant energy preparing for the unknown.

Controlled Substances 142

Controlled Substances Patient Care 142

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

OCTOBER 10, 2024

Guselkumab is currently approved by the FDA to treat adults with moderate to severe plaque psoriasis, adults with active psoriatic arthritis, and adults with moderately to severely active ulcerative colitis.

FDA 216

FDA 216

STAT

OCTOBER 10, 2024

The director general of the Africa Centres for Disease Control and Prevention and Rwanda’s health minister on Thursday criticized the U.S. government’s decision to urge Americans to avoid travel to Rwanda because of the country’s ongoing Marburg outbreak. Calling the travel alert a travel ban — it is not — Jean Kaseya, who heads the Africa CDC, suggested the U.S. action was counterproductive and unfair to a country that is being transparent about its efforts to

139

139

STAT

OCTOBER 10, 2024

Amid excitement over everything from Chat-GPT to Nobel Prize-winning chemistry research that uses artificial intelligence to predict protein structures, academics Aravind Narayan and Sayash Kapoor have established a reputation for throwing cold water on at least some of the claims about how AI will transform people’s lives.  Narayan, a professor of computer science at Princeton University, went viral in 2019 for a talk he gave at MIT on how to recognize overblown declarations about A

Hospitals 138

Hospitals 138

Drug Topics

OCTOBER 10, 2024

GSK’s respiratory syncytial virus vaccine continued to provide adults aged 60 years and older with clinically meaningful protection.

Vaccines 216

Vaccines 216

STAT

OCTOBER 10, 2024

Bill Nye the Science Guy is temporarily rebranding. For now, he’s “ Bill Nye the Ataxia Advocate Guy ,” as he aims to bring awareness to a neurological disease that has affected his family for generations. Nye has previously spoken about the genetic disease, which makes it difficult for people with the condition to control their muscles and often leads to problems with walking and speech, in a documentary released in 2017.

136

136

Drug Topics

OCTOBER 10, 2024

The COVID-19 pandemic negatively impacted mental health in young people, and additional targeted mental health resources are needed.

216

216

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 10, 2024

This story was first published in the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Sarepta Therapeutics CEO Doug Ingram is upset about the company’s slumping stock price.  Investors who have interacted with him this summer, including during a whitewater rafting trip, told me Ingram has been venting his frustration to anyone who will listen.

133

133

Drug Topics

OCTOBER 10, 2024

The therapy’s Prescription Drug User Fee Act date has been set for July 26, 2025.

FDA 216

FDA 216

PharmaVoice

OCTOBER 10, 2024

Despite the drug’s wide patient pool, Madrigal is taking a targeted approach with its first launch.

130

130

Drug Topics

OCTOBER 10, 2024

This year’s annual meeting of the American College of Chest Physicians featured more than 300 educational sessions, insights from over 600 faculty members, and 29.5 hours of CE credits.

216

216

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

OCTOBER 10, 2024

Although Regeneron has been playing catch-up in the oncology field for years, a pipeline built on next-wave promises could push the boundaries.

130

130

STAT

OCTOBER 10, 2024

In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order to boost usage of a pricey medicine. Separately, the drugmaker agreed to pay $25 million to settle charges of participating in a price-fixing scheme with other generic companies.

Pharmaceutical Companies 128

Pharmaceutical Companies Pharmaceutical Companies 128

Fierce Healthcare

OCTOBER 10, 2024

Just 40% of Medicare Advantage prescription drug plans offered in 2025 achieved a score of four stars or higher, the Centers for Medicare & Medicaid Services (CMS) revealed Oct. 10. | It's harder than ever for Medicare Advantage plans to score well on star ratings. Here's how they performed for 2025.

126

126

STAT

OCTOBER 10, 2024

On Thursday, the CDC released new data showing that almost 15.5 million U.S. adults are living with ADHD. More than half of those individuals received their diagnosis in adulthood.   That includes me. The diagnosis came as a relief and validation — a way to understand years of impulsivity, inattention, and struggles with daily life. I was diagnosed at age 36, after first one, then two, and ultimately, four of my five children were also diagnosed with ADHD.

126

126

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

OCTOBER 10, 2024

Suki, a voice-assistive AI and medical scribe tool, secured $70 million in fresh funding to build out its AI assistant technology for doctors and hospitals. | Suki, a voice-assistive AI and medical scribe tool, secured $70 million in fresh funding to build out its AI assistant technology for doctors and hospitals.

Hospitals 124

Hospitals 124

Pharmacy Times

OCTOBER 10, 2024

Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.

123

123

STAT

OCTOBER 10, 2024

How does John Maraganore decide which startups to get involved in? Why are longevity-minded tech bros getting involved with a controversial CRISPR scientist? And who would you rather hang out with at the STAT Summit next week, Adam or Allison? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.

117

117

Pharmacy Times

OCTOBER 10, 2024

Although the findings indicate a potential for predicting asthma or wheezing onset, these trends cannot yet be used for early diagnoses in individual children.

117

117

pharmaphorum

OCTOBER 10, 2024

Media personality Nadia Sawalha is heading a fundraising effort to launch an appeal against NICE's recent rejection of a breast cancer therapy Enhertu.

115

115

STAT

OCTOBER 10, 2024

U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.

Packaging 115

Packaging Pharmaceutical Companies Pharmaceutical Companies 115

Fierce Healthcare

OCTOBER 10, 2024

Melinda French Gates has announced a $250 million fund to improve women’s mental and physical health. | Action for Women’s Health will fund nonprofit organizations globally working to improve women’s mental and physical health. Awards will range from $1 million to $5 million, to be announced by the end of 2025.

115

115

STAT

OCTOBER 10, 2024

The ink had scarcely dried on  new federal rules  for enforcement of the Mental Health Parity and Addiction Equity Act of 2008 when U.S. health plans  threatened potential legal action  to block them.  Buoyed by a recent Supreme Court ruling that  shifts power away from federal agencies , health plans apparently hope to keep the departments of Labor, Treasury, and Health and Human Services from making parity a reality, years after Congress passed the law with r

115

115

Pharmacy Times

OCTOBER 10, 2024

The FDA also approved the FoundationOne Liquid CDx assay as a companion diagnostic device to identify patients who would benefit from the treatment.

FDA 114

FDA 114

STAT

OCTOBER 10, 2024

Over the past decade, there has been a clear and unprecedented exodus of young life scientists from academia and into lucrative industry jobs. But new data provide evidence that this trend is slowing, at least for now. The latest numbers from the Survey of Earned Doctorates, an annual National Science Foundation census of freshly minted Ph.D. graduates, show that 61.6% of biomedical scientists who had a job lined up were bound for industry in 2023.

115

115

pharmaphorum

OCTOBER 10, 2024

Starboard Value alleges former Pfizer execs Ian Read and Frank D'Amelio were bullied into lending their support to current management

111

111

STAT

OCTOBER 10, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Morning. Today, we are sad to report that more children have developed blood cancers after receiving Bluebird Bio’s CALD gene therapy, Skysona. There’s a new twist in the Pfizer activist shareholder campaign.

113

113

pharmaphorum

OCTOBER 10, 2024

EVERSANA partners Oracle on pharmacovigilance platform Phil.

111

111

Outsourcing Pharma

OCTOBER 10, 2024

The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical Group for access to an experimental small molecule treatment for dyslipidemia.

109

109

STAT

OCTOBER 10, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Lilly appoints Chief AI Officer Drug giant Eli Lilly announced Thomas Fuchs as its first chief AI officer. Previously, Fuchs was director of the Hasso Plattner Institute for Digital Health at Mount Sinai in New York where he helped lead work on computational pathology.

106

106